Epidemiology of chemotherapy-induced neutropenia at a tertiary university hospital in Oman

被引:5
|
作者
Abou Saleh, Maram [1 ]
Mafiana, Rose Ngozi [2 ]
Al Za'abi, Mohammed [1 ]
Vaishnav, Ragini [1 ]
Al Kindi, Salam [3 ]
Al-Zakwani, Ibrahim [1 ,4 ]
机构
[1] Sultan Qaboos Univ, Dept Pharmacol & Clin Pharm, Coll Med & Hlth Sci, Muscat, Oman
[2] Sultan Qaboos Univ Hosp, Dept Pharm, Muscat 123, Oman
[3] Sultan Qaboos Univ, Dept Hematol, Coll Med & Hlth Sci, Muscat, Oman
[4] Gulf Hlth Res, Muscat, Oman
关键词
Febrile neutropenia; Incidence; Length of hospital stay; Neutropenia; Oman; FEBRILE NEUTROPENIA; CANCER-PATIENTS; IMPACT;
D O I
10.1007/s11096-013-9859-8
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background Little is known about the incidence and burden of chemotherapy-induced neutropenia (CIN) in Oman or the Arabian Gulf. Objectives To determine the epidemiology of CIN at Sultan Qaboos University Hospital in Oman. Methods A retrospective observational study of all eligible CIN episodes in adult (> 18 years) patients with solid tumors and hematological malignancies at Sultan Qaboos University Hospital (SQUH) from January to December 2010. Analyses were performed using univariate statistics. Results A total of 1,357 episodes in 159 patients with a mean age of 50 +/- A 15 years (19-91) were evaluated. Fifty-four percent (n = 86) of the patients were female. A total of 46 % (73/159) of the patients developed CIN accounting for 15 % (210/1,357) of all episodes. Twelve percent (25/210) of these CIN episodes were associated with fever in 26 % (19/73) patients. There was significant association between CIN and chemotherapy regimen (P < 0.001), younger age (P < 0.001), low hemoglobin (Hb) levels (P < 0.001) and advanced cancer stage (P = 0.006). Conclusions This study suggests a high incidence of CIN in SQUH patients which resulted in chemotherapy delays, longer hospital stays, and inpatient mortality. CIN was significantly correlated with chemotherapy regimen, younger age, low Hb levels and cancer stage.
引用
收藏
页码:1036 / 1039
页数:4
相关论文
共 50 条
  • [1] Epidemiology of chemotherapy-induced neutropenia at a tertiary university hospital in Oman
    Maram Abou Saleh
    Rose Ngozi Mafiana
    Mohammed Al Za’abi
    Ragini Vaishnav
    Salam Al Kindi
    Ibrahim Al-Zakwani
    International Journal of Clinical Pharmacy, 2013, 35 : 1036 - 1039
  • [2] Chemotherapy-induced neutropenia among breast Cancer patients in a tertiary care hospital: Risk and consequences
    Joseph, Anu
    Joshua, Julie Mariam
    Mathews, Santhosh M.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2023, 29 (03) : 529 - 533
  • [3] Lipegfilgrastim for prophylaxis of chemotherapy-induced neutropenia in Dutch patients
    Timmer-Bonte, J. N. H.
    Ouwerkerk, J.
    Faber, L. M.
    Kerkhofs, L. G. M.
    Laterveer, L.
    ten Oever, D.
    van Rees, B. P.
    van der Linden, P. W.
    NETHERLANDS JOURNAL OF MEDICINE, 2020, 78 (05) : 270 - 276
  • [4] Antimicrobial agent prescription patterns for chemotherapy-induced febrile neutropenia in patients with hematological malignancies at Sultan Qaboos University Hospital, Oman
    Al Balushi, K. A.
    Balkhair, A.
    Ali, B. H.
    Al Rawas, N.
    JOURNAL OF INFECTION AND PUBLIC HEALTH, 2013, 6 (03) : 216 - 221
  • [5] Validation of Risk of Chemotherapy-Induced Neutropenia: Experience from Oncology Hospital of Nepal
    Sapkota, Binaya
    Shrestha, Ronash
    Chapagai, Safin
    Shakya, Dip Kiran
    Bista, Prashant
    CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 3751 - 3758
  • [6] Chemotherapy-induced neutropenia and febrile neutropenia in patients with gynecologic malignancy
    Hashiguchi, Yasunori
    Kasai, Mari
    Fukuda, Takeshi
    Ichimura, Tomoyuki
    Yasui, Tomoyo
    Sumi, Toshiyuki
    ANTI-CANCER DRUGS, 2015, 26 (10) : 1054 - 1060
  • [7] Management of Breast Cancer Patients with Chemotherapy-Induced Neutropenia or Febrile Neutropenia
    Fontanella, Caterina
    Bolzonello, Silvia
    Lederer, Bianca
    Aprile, Giuseppe
    BREAST CARE, 2014, 9 (04) : 239 - 245
  • [8] Spotlight on Pegfilgrastim in Chemotherapy-Induced Neutropenia
    James E. Frampton
    Gillian M. Keating
    BioDrugs, 2005, 19 : 405 - 407
  • [9] The colony stimulating factors for the management of chemotherapy-induced neutropenia
    Dale, David C.
    ONCOLOGY IN CLINICAL PRACTICE, 2005, 1 (01): : 49 - 53
  • [10] Assessment of chemotherapy-induced febrile neutropenia in cancer patients
    Philip, Malona Lilly
    Saj, Neethu
    Sebastian, Antony Mathew
    Mateti, Uday Venkat
    Shetty, Vijith
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2019, 40 (02) : 249 - 256